CinnaGen protein subunit Covid-19 vaccine Ph III results
16 Sep 2021 //
CLINICALTRIALSARENA
Iranian drugmaker opens $100M plant in Turkey, will make Humira biosimilar
13 Jun 2019 //
FIERCE PHARMA
First MENA MAb manufacturer gets EMA GMP certificate
03 Sep 2018 //
PHARMA LETTER
CinnaGen in new signal of intent to target EU biosimilars market
10 Aug 2018 //
PHARMA LETTER
CinnaGen CEO not holding back in ambition to be a global player
15 Jul 2018 //
THEPHARMALETTER